MarketCap
Facebook
X
TelegramQuarterly report 2023-Q3
added 11-22-2023
NantHealth Balance Sheet 2011-2026 | NH
Annual Balance Sheet NantHealth
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
4.4 M | -20.9 M | -22.5 M | 201 M | 182 M | 134 M | 30.7 M | -5.99 M | 30.8 M | - | - | - |
Long Term Debt |
4.05 M | 6.25 M | - | 206 M | 200 M | 195 M | 191 M | - | - | - | - | - |
Long Term Debt Current |
2.1 M | 1.91 M | 1.9 M | 1.92 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 266 M | 247 M | 220 M | 215 M | 184 M | 159 M | - | - | - |
Total Current Liabilities |
35.6 M | 27.9 M | 125 M | 57.5 M | 36.5 M | 35.9 M | 57.2 M | - | - | - | - | - |
Total Liabilities |
385 M | 360 M | 312 M | 324 M | 284 M | 256 M | 273 M | 227 M | 246 M | - | - | - |
Deferred Revenue |
2.72 M | 2.44 M | 1.17 M | 16.7 M | 16.3 M | 10.1 M | 17.2 M | 10.7 M | 24.1 M | - | - | - |
Retained Earnings |
-1.12 B | -1.05 B | - | -947 M | -884 M | -693 M | -475 M | -291 M | -219 M | - | - | - |
Total Assets |
160 M | 198 M | 190 M | 266 M | 286 M | 449 M | 684 M | 412 M | 311 M | - | - | - |
Cash and Cash Equivalents |
1.76 M | 29.1 M | 22.8 M | 5.24 M | 18.3 M | 61.7 M | 160 M | 5.99 M | - | - | - | - |
Book Value |
-225 M | -162 M | -122 M | -57.1 M | 2.83 M | 193 M | 412 M | 185 M | 64.8 M | - | - | - |
Total Shareholders Equity |
-225 M | -162 M | -112 M | -57.1 M | 2.83 M | 193 M | 412 M | 185 M | 64.8 M | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet NantHealth
| 2023-Q3 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
2.18 M | 3.32 M | 4.05 M | 4.55 M | - | 5.71 M | 6.25 M | 6.88 M | 7.26 M | 7.72 M | 8.17 M | 8.17 M | 8.17 M | 8.17 M | 9.73 M | 9.73 M | 9.73 M | 9.73 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
397 M | 406 M | 385 M | 362 M | - | 358 M | 360 M | 364 M | 361 M | 320 M | 312 M | 312 M | 312 M | 312 M | 324 M | 324 M | 324 M | 324 M | 284 M | 284 M | 284 M | 284 M | 256 M | 256 M | 256 M | 256 M | 273 M | 273 M | 273 M | 273 M | 60.9 M | 60.9 M | 60.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
2.14 M | 3.41 M | 2.72 M | 2.66 M | - | 2.7 M | 2.44 M | 1.94 M | 1.25 M | 1.22 M | 1.17 M | 1.17 M | 1.17 M | 1.17 M | 7.1 M | 7.1 M | 7.1 M | 7.1 M | 16.3 M | 16.3 M | 16.3 M | 13.1 M | 10.1 M | 9.2 M | 18.7 M | 16.5 M | 9.6 M | 9.6 M | 17.2 M | 17.2 M | 10.7 M | 10.7 M | 10.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-1.17 B | -1.13 B | -1.12 B | -1.1 B | - | -1.07 B | -1.05 B | -1.04 B | -1.03 B | -1.01 B | -1 B | -1 B | -1 B | -1 B | -947 M | -947 M | -947 M | -947 M | -884 M | -884 M | -884 M | -884 M | -693 M | -693 M | -693 M | -693 M | -475 M | -475 M | -475 M | -475 M | -291 M | -291 M | -291 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
146 M | 170 M | 160 M | 161 M | - | 181 M | 198 M | 217 M | 225 M | 188 M | 200 M | 200 M | 200 M | 200 M | 266 M | 266 M | 266 M | 266 M | 286 M | 286 M | 286 M | 286 M | 449 M | 449 M | 449 M | 449 M | 684 M | 684 M | 684 M | 684 M | 412 M | 412 M | 412 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
5.82 M | 14.1 M | 1.76 M | 2.44 M | - | 18.3 M | 29.1 M | 47.8 M | 52 M | 10.8 M | 22.8 M | 22.8 M | 22.8 M | 22.8 M | 5.24 M | 5.24 M | 5.24 M | 5.24 M | 18.3 M | 18.3 M | 18.3 M | 18.3 M | 61.7 M | 61.7 M | 61.7 M | 61.7 M | 158 M | 158 M | 160 M | 160 M | 5.99 M | 5.99 M | 5.99 M | - | 3.7 M | - | - | - | 17 M | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
-250 M | -237 M | -225 M | -201 M | - | -177 M | -162 M | -147 M | -136 M | -132 M | -111 M | -111 M | -111 M | -111 M | -57.1 M | -57.1 M | -57.1 M | -57.1 M | 2.83 M | 2.83 M | 2.83 M | 2.83 M | 193 M | 193 M | 193 M | 193 M | 412 M | 412 M | 412 M | 412 M | 351 M | 351 M | 351 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
-250 M | -237 M | -225 M | -201 M | -188 M | -177 M | -162 M | -147 M | -136 M | -132 M | -112 M | -112 M | -112 M | -112 M | -57.1 M | -57.1 M | -57.1 M | -57.1 M | 2.83 M | 2.83 M | 2.83 M | 2.83 M | 193 M | 193 M | 193 M | 193 M | 412 M | 412 M | 412 M | 412 M | 185 M | 185 M | 185 M | - | 64.8 M | - | - | - | 20.7 M | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Balance Sheet is a fundamental financial report of NantHealth, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
Balance sheet of other industry stocks – Health information services
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
Accolade
ACCD
|
- | 0.29 % | $ 206 M |  USA |
 |
Change Healthcare
CHNG
|
- | - | $ 9.03 B | USA |
 |
Phreesia
PHR
|
$ 11.27 | -0.13 % | $ 615 M | USA |
 |
Cerner Corporation
CERN
|
- | - | $ 27.9 B | USA |
 |
American Well Corporation
AMWL
|
$ 5.77 | 0.17 % | $ 92.6 M | USA |
 |
Computer Programs and Systems
CPSI
|
- | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
- | - | $ 2.94 B | USA |
 |
Schrödinger
SDGR
|
$ 11.51 | -0.52 % | $ 845 M | USA |
 |
iCAD
ICAD
|
- | - | $ 102 M | USA |
 |
Castlight Health, Inc.
CSLT
|
- | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
- | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
- | - | $ 6.37 B | USA |
 |
Teladoc Health
TDOC
|
$ 5.57 | 2.87 % | $ 982 M | USA |
 |
NextGen Healthcare
NXGN
|
- | - | $ 1.6 B | USA |
 |
1Life Healthcare
ONEM
|
- | - | $ 3.37 B | USA |
 |
Premier
PINC
|
- | - | $ 2.33 B | USA |
 |
Omnicell
OMCL
|
$ 34.87 | 1.19 % | $ 1.61 B | USA |
 |
OptimizeRx Corporation
OPRX
|
$ 7.15 | 5.38 % | $ 122 M | USA |
 |
Evolent Health
EVH
|
$ 2.28 | 1.11 % | $ 214 M | USA |
 |
MTBC
MTBC
|
- | -0.58 % | $ 51.7 M | USA |
 |
SCWorx Corp.
WORX
|
$ 0.13 | 3.86 % | $ 190 K | USA |
 |
GoodRx Holdings
GDRX
|
$ 2.07 | 1.23 % | $ 798 M | USA |
 |
Signify Health
SGFY
|
- | -0.02 % | $ 7.21 B | USA |
 |
Zhongchao
ZCMD
|
$ 1.82 | 0.28 % | $ 9.47 M |  China |
 |
R1 RCM
RCM
|
- | - | $ 3.81 B | USA |
 |
Akerna Corp.
KERN
|
- | - | $ 161 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
- | -10.39 % | $ 886 M | USA |
 |
Health Catalyst
HCAT
|
$ 1.11 | 0.91 % | $ 77.6 M | USA |
 |
HealthEquity
HQY
|
$ 81.92 | -0.23 % | $ 7.06 B | USA |
 |
HealthStream
HSTM
|
$ 21.18 | 1.0 % | $ 644 M | USA |
 |
10x Genomics
TXG
|
$ 20.98 | 5.91 % | $ 2.46 B | USA |
 |
Streamline Health Solutions
STRM
|
- | - | $ 21.4 M | USA |
 |
Tabula Rasa HealthCare
TRHC
|
- | - | $ 255 M | USA |
 |
Progyny
PGNY
|
$ 17.65 | -2.22 % | $ 1.51 B | USA |
 |
So-Young International
SY
|
$ 3.11 | 6.87 % | $ 247 M | China |
 |
Veeva Systems
VEEV
|
$ 178.22 | -0.5 % | $ 29.2 B | USA |